Literature DB >> 21123539

Comparison of the level, distribution and form of disease-associated prion protein in variant and sporadic Creutzfeldt-Jakob diseased brain using conformation-dependent immunoassay and Western blot.

Young Pyo Choi1, Albrecht Gröner, James W Ironside, Mark W Head.   

Abstract

Disease-associated prion protein (PrP(Sc)) can be distinguished from the cellular isoform (PrP(C)) by conformation-dependent immunoassay (CDI). This technique exploits the presence of an epitope, accessible in PrP(C), but only unmasked by denaturation in PrP(Sc). In this study, we investigated PrP(Sc) in different brain regions in variant and sporadic Creutzfeldt-Jakob disease (CJD) by using CDI, and directly compared the results with those obtained using the more commonly employed protease digestion and Western blotting. In general, there was good agreement between the results, although there were certain discrepancies in relative abundance when the regional distribution in variant CJD cases was considered. The results largely confirmed the previously described targeting of different brain regions by variant and sporadic CJD. Additionally, the combination of protease digestion and CDI detection demonstrated, for the first time, the presence of PrP(Sc) in variant CJD brains that is susceptible to proteolysis under standard conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123539     DOI: 10.1099/vir.0.026948-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

Authors:  Mark L Cohen; Chae Kim; Tracy Haldiman; Mohamed ElHag; Prachi Mehndiratta; Termsarasab Pichet; Frances Lissemore; Michelle Shea; Yvonne Cohen; Wei Chen; Janis Blevins; Brian S Appleby; Krystyna Surewicz; Witold K Surewicz; Martha Sajatovic; Curtis Tatsuoka; Shulin Zhang; Ping Mayo; Mariusz Butkiewicz; Jonathan L Haines; Alan J Lerner; Jiri G Safar
Journal:  Brain       Date:  2015-02-15       Impact factor: 13.501

2.  Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.

Authors:  Charles E Mays; Jacques van der Merwe; Chae Kim; Tracy Haldiman; Debbie McKenzie; Jiri G Safar; David Westaway
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

3.  Prion disease tempo determined by host-dependent substrate reduction.

Authors:  Charles E Mays; Chae Kim; Tracy Haldiman; Jacques van der Merwe; Agnes Lau; Jing Yang; Jennifer Grams; Michele A Di Bari; Romolo Nonno; Glenn C Telling; Qingzhong Kong; Jan Langeveld; Debbie McKenzie; David Westaway; Jiri G Safar
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

4.  Co-existence of distinct prion types enables conformational evolution of human PrPSc by competitive selection.

Authors:  Tracy Haldiman; Chae Kim; Yvonne Cohen; Wei Chen; Janis Blevins; Liuting Qing; Mark L Cohen; Jan Langeveld; Glenn C Telling; Qingzhong Kong; Jiri G Safar
Journal:  J Biol Chem       Date:  2013-08-23       Impact factor: 5.157

5.  Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.

Authors:  Alexander H Peden; Lynne I McGuire; Nigel E J Appleford; Gary Mallinson; Jason M Wilham; Christina D Orrú; Byron Caughey; James W Ironside; Richard S Knight; Robert G Will; Alison J E Green; Mark W Head
Journal:  J Gen Virol       Date:  2011-10-26       Impact factor: 3.891

6.  Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate.

Authors:  Chae Kim; Tracy Haldiman; Yvonne Cohen; Wei Chen; Janis Blevins; Man-Sun Sy; Mark Cohen; Jiri G Safar
Journal:  PLoS Pathog       Date:  2011-09-08       Impact factor: 6.823

7.  Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?

Authors:  Gabor G Kovacs; Alexander Peden; Serge Weis; Romana Höftberger; Anna S Berghoff; Helen Yull; Thomas Ströbel; Stefan Koppi; Regina Katzenschlager; Dieter Langenscheidt; Hamid Assar; Elisabeth Zaruba; Albrecht Gröner; Till Voigtländer; Gina Puska; Eva Hametner; Astrid Grams; Armin Muigg; Michael Knoflach; Lajos László; James W Ironside; Mark W Head; Herbert Budka
Journal:  Acta Neuropathol Commun       Date:  2013-11-11       Impact factor: 7.801

8.  The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease.

Authors:  Alexander H Peden; Deep P Sarode; Carl R Mulholland; Marcelo A Barria; Diane L Ritchie; James W Ironside; Mark W Head
Journal:  Acta Neuropathol Commun       Date:  2014-10-21       Impact factor: 7.801

9.  Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.

Authors:  Young Pyo Choi; Mark W Head; James W Ironside; Suzette A Priola
Journal:  Am J Pathol       Date:  2014-09-30       Impact factor: 4.307

10.  Regional distribution of anchorless prion protein, PrP226*, in the human brain.

Authors:  Anja Lukan; Maja Černilec; Tanja Vranac; Mara Popović; Vladka Čurin Šerbec
Journal:  Prion       Date:  2014-02-28       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.